

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | low-density lipoprotein particle clearance (GO:0034383) | 4.57966049 |
| 2 | glycosphingolipid catabolic process (GO:0046479) | 4.14581262 |
| 3 | daunorubicin metabolic process (GO:0044597) | 4.10551132 |
| 4 | polyketide metabolic process (GO:0030638) | 4.10551132 |
| 5 | doxorubicin metabolic process (GO:0044598) | 4.10551132 |
| 6 | oligosaccharide catabolic process (GO:0009313) | 3.96423690 |
| 7 | glycolipid catabolic process (GO:0019377) | 3.88377682 |
| 8 | COPI coating of Golgi vesicle (GO:0048205) | 3.85634129 |
| 9 | Golgi transport vesicle coating (GO:0048200) | 3.85634129 |
| 10 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.74926241 |
| 11 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.59813466 |
| 12 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.53778707 |
| 13 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.44172347 |
| 14 | barbed-end actin filament capping (GO:0051016) | 3.37553186 |
| 15 | pentose-phosphate shunt (GO:0006098) | 3.34395086 |
| 16 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.33835441 |
| 17 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.30974756 |
| 18 | ceramide catabolic process (GO:0046514) | 3.30146593 |
| 19 | positive regulation of extracellular matrix organization (GO:1903055) | 3.29203612 |
| 20 | pinocytosis (GO:0006907) | 3.27720176 |
| 21 | regulation of vitamin metabolic process (GO:0030656) | 3.24819270 |
| 22 | glycoside metabolic process (GO:0016137) | 3.24297644 |
| 23 | skin morphogenesis (GO:0043589) | 3.22457245 |
| 24 | plasma lipoprotein particle clearance (GO:0034381) | 3.21038978 |
| 25 | negative regulation of interleukin-12 production (GO:0032695) | 3.14217293 |
| 26 | response to thyroid hormone (GO:0097066) | 3.11151941 |
| 27 | membrane lipid catabolic process (GO:0046466) | 3.08414462 |
| 28 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.05528872 |
| 29 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.05528872 |
| 30 | modulation by symbiont of host immune response (GO:0052553) | 3.05528872 |
| 31 | positive regulation by symbiont of host defense response (GO:0052509) | 3.05528872 |
| 32 | modulation by symbiont of host defense response (GO:0052031) | 3.05528872 |
| 33 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.05528872 |
| 34 | NADPH regeneration (GO:0006740) | 3.03474467 |
| 35 | stress fiber assembly (GO:0043149) | 3.03201649 |
| 36 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.02347542 |
| 37 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.00163427 |
| 38 | positive regulation of heat generation (GO:0031652) | 2.99383940 |
| 39 | macroautophagy (GO:0016236) | 2.97669787 |
| 40 | neutrophil activation involved in immune response (GO:0002283) | 2.96462734 |
| 41 | cysteine metabolic process (GO:0006534) | 2.94205158 |
| 42 | glucose 6-phosphate metabolic process (GO:0051156) | 2.90741138 |
| 43 | iron ion import (GO:0097286) | 2.88359655 |
| 44 | hemidesmosome assembly (GO:0031581) | 2.86896394 |
| 45 | regulation of fever generation (GO:0031620) | 2.84397198 |
| 46 | macrophage activation involved in immune response (GO:0002281) | 2.84015483 |
| 47 | decidualization (GO:0046697) | 2.82634056 |
| 48 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.82630913 |
| 49 | progesterone metabolic process (GO:0042448) | 2.82562299 |
| 50 | detection of molecule of bacterial origin (GO:0032490) | 2.82412470 |
| 51 | hyaluronan catabolic process (GO:0030214) | 2.81317731 |
| 52 | sphingolipid catabolic process (GO:0030149) | 2.81226820 |
| 53 | cyclooxygenase pathway (GO:0019371) | 2.81068025 |
| 54 | protein localization to endosome (GO:0036010) | 2.80731943 |
| 55 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.80479389 |
| 56 | aldehyde catabolic process (GO:0046185) | 2.80355425 |
| 57 | phagosome maturation (GO:0090382) | 2.79555097 |
| 58 | regulation of cholesterol storage (GO:0010885) | 2.78183820 |
| 59 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.71984648 |
| 60 | NIK/NF-kappaB signaling (GO:0038061) | 2.71032273 |
| 61 | regulation of superoxide anion generation (GO:0032928) | 2.70951696 |
| 62 | regulation of chemokine biosynthetic process (GO:0045073) | 2.70138740 |
| 63 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.66973062 |
| 64 | response to laminar fluid shear stress (GO:0034616) | 2.65954921 |
| 65 | positive regulation of leukocyte degranulation (GO:0043302) | 2.65130316 |
| 66 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.63048049 |
| 67 | membrane raft organization (GO:0031579) | 2.62837331 |
| 68 | glucose catabolic process (GO:0006007) | 2.62698329 |
| 69 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.62289994 |
| 70 | epithelial cell-cell adhesion (GO:0090136) | 2.60822105 |
| 71 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.55680829 |
| 72 | regulation of mononuclear cell migration (GO:0071675) | 2.55589605 |
| 73 | positive regulation of p38MAPK cascade (GO:1900745) | 2.54952496 |
| 74 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.54705999 |
| 75 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.53604863 |
| 76 | hypotonic response (GO:0006971) | 2.53441211 |
| 77 | eosinophil chemotaxis (GO:0048245) | 2.51770238 |
| 78 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.51221048 |
| 79 | cellular copper ion homeostasis (GO:0006878) | 2.50521593 |
| 80 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.49291254 |
| 81 | amino sugar catabolic process (GO:0046348) | 2.49124224 |
| 82 | reactive oxygen species biosynthetic process (GO:1903409) | 2.48280041 |
| 83 | regulation of podosome assembly (GO:0071801) | 2.47847052 |
| 84 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.46558877 |
| 85 | mammary gland epithelial cell proliferation (GO:0033598) | 2.46284828 |
| 86 | cellular response to arsenic-containing substance (GO:0071243) | 2.46210143 |
| 87 | positive regulation of lipid storage (GO:0010884) | 2.43704068 |
| 88 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.43694666 |
| 89 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.42953534 |
| 90 | negative regulation of amino acid transport (GO:0051956) | 2.42941513 |
| 91 | regulation of leukocyte degranulation (GO:0043300) | 2.42446544 |
| 92 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.41239862 |
| 93 | apoptotic cell clearance (GO:0043277) | 2.41109640 |
| 94 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.40654300 |
| 95 | cofactor catabolic process (GO:0051187) | 2.38440643 |
| 96 | acute-phase response (GO:0006953) | 2.37608355 |
| 97 | osteoclast differentiation (GO:0030316) | 2.37385018 |
| 98 | respiratory burst (GO:0045730) | 2.36938823 |
| 99 | growth hormone receptor signaling pathway (GO:0060396) | 2.36859373 |
| 100 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.36218603 |
| 101 | protein retention in ER lumen (GO:0006621) | 2.36099215 |
| 102 | lipoprotein transport (GO:0042953) | 2.35464326 |
| 103 | regulation of macrophage chemotaxis (GO:0010758) | 2.35163217 |
| 104 | L-ascorbic acid metabolic process (GO:0019852) | 2.34213181 |
| 105 | modulation by symbiont of host cellular process (GO:0044068) | 2.33760664 |
| 106 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.32977203 |
| 107 | cell-substrate junction assembly (GO:0007044) | 2.32803184 |
| 108 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.32586312 |
| 109 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.32106602 |
| 110 | phospholipid efflux (GO:0033700) | 2.31752392 |
| 111 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.30367002 |
| 112 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.29812171 |
| 113 | positive regulation of nuclease activity (GO:0032075) | 2.28762085 |
| 114 | regulation of early endosome to late endosome transport (GO:2000641) | 2.28698663 |
| 115 | response to manganese ion (GO:0010042) | 2.28444050 |
| 116 | response to peptidoglycan (GO:0032494) | 2.27345176 |
| 117 | ER-nucleus signaling pathway (GO:0006984) | 2.26506173 |
| 118 | proline transport (GO:0015824) | 2.26113917 |
| 119 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.25555360 |
| 120 | response to progesterone (GO:0032570) | 2.25313039 |
| 121 | regulation of cholesterol homeostasis (GO:2000188) | 2.25095401 |
| 122 | eosinophil migration (GO:0072677) | 2.24627260 |
| 123 | substrate-dependent cell migration (GO:0006929) | 2.24375802 |
| 124 | regulation of metalloenzyme activity (GO:0048552) | 2.24337137 |
| 125 | cholesterol efflux (GO:0033344) | 2.23790271 |
| 126 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.23762495 |
| 127 | positive regulation of bone resorption (GO:0045780) | 2.23502776 |
| 128 | positive regulation of bone remodeling (GO:0046852) | 2.23502776 |
| 129 | protein-lipid complex assembly (GO:0065005) | 2.22630846 |
| 130 | negative regulation of lipid storage (GO:0010888) | 2.22064113 |
| 131 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.21902475 |
| 132 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.20171947 |
| 133 | fructose metabolic process (GO:0006000) | 2.18783313 |
| 134 | phagocytosis, recognition (GO:0006910) | 2.18774514 |
| 135 | positive regulation of interferon-alpha production (GO:0032727) | 2.18429507 |
| 136 | protein carboxylation (GO:0018214) | 2.17817455 |
| 137 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.17817455 |
| 138 | superoxide anion generation (GO:0042554) | 2.15871114 |
| 139 | regulation of heat generation (GO:0031650) | 2.15804869 |
| 140 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.15595547 |
| 141 | natural killer cell mediated immunity (GO:0002228) | 2.15595547 |
| 142 | wound healing, spreading of epidermal cells (GO:0035313) | 2.15289963 |
| 143 | cell adhesion mediated by integrin (GO:0033627) | 2.14871841 |
| 144 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.14865731 |
| 145 | sexual reproduction (GO:0019953) | 2.13984838 |
| 146 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.13923638 |
| 147 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.12625419 |
| 148 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.11424115 |
| 149 | plasma lipoprotein particle assembly (GO:0034377) | 2.11121142 |
| 150 | transferrin transport (GO:0033572) | 2.11051186 |
| 151 | glucuronate metabolic process (GO:0019585) | 2.09429279 |
| 152 | uronic acid metabolic process (GO:0006063) | 2.09429279 |
| 153 | positive regulation of lipid catabolic process (GO:0050996) | 2.09392394 |
| 154 | alanine transport (GO:0032328) | 2.09267821 |
| 155 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.08252215 |
| 156 | regulation of interferon-alpha production (GO:0032647) | 2.07808381 |
| 157 | fibrinolysis (GO:0042730) | 2.07544605 |
| 158 | urea metabolic process (GO:0019627) | 2.05254158 |
| 159 | urea cycle (GO:0000050) | 2.05254158 |
| 160 | cellular response to nicotine (GO:0071316) | 2.04670067 |
| 161 | cellular response to ATP (GO:0071318) | 2.04237145 |
| 162 | cellular response to growth hormone stimulus (GO:0071378) | 2.03738856 |
| 163 | response to host immune response (GO:0052572) | 2.03489217 |
| 164 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.03489217 |
| 165 | granulocyte activation (GO:0036230) | 2.02776975 |
| 166 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.02729793 |
| 167 | trivalent inorganic cation transport (GO:0072512) | 2.02465751 |
| 168 | ferric iron transport (GO:0015682) | 2.02465751 |
| 169 | response to arsenic-containing substance (GO:0046685) | 2.02392927 |
| 170 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.01624057 |
| 171 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.01624057 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.49294919 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.33813406 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.84480222 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.70189753 |
| 5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.66514518 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.62504681 |
| 7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.39544404 |
| 8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.36577800 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.35532809 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.32170253 |
| 11 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.30602381 |
| 12 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.29607751 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.25996672 |
| 14 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.17998751 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.15408909 |
| 16 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.08658514 |
| 17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.07059461 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.04167290 |
| 19 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.01365717 |
| 20 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.00937130 |
| 21 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.96506375 |
| 22 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.96506375 |
| 23 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.79836811 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.76969843 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.72377027 |
| 26 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.68020370 |
| 27 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.67149998 |
| 28 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.66239302 |
| 29 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.62885043 |
| 30 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.58941658 |
| 31 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.57220099 |
| 32 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.56895195 |
| 33 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.55243950 |
| 34 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.50781671 |
| 35 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.46422797 |
| 36 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.43005606 |
| 37 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.42967495 |
| 38 | MYC_22102868_ChIP-Seq_BL_Human | 1.42920520 |
| 39 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42736653 |
| 40 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.42147317 |
| 41 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.41639243 |
| 42 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.40788652 |
| 43 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.39832049 |
| 44 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.39262537 |
| 45 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.37033928 |
| 46 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.36719608 |
| 47 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.36109192 |
| 48 | RXR_22108803_ChIP-Seq_LS180_Human | 1.35890368 |
| 49 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.34590484 |
| 50 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.34497384 |
| 51 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.34293344 |
| 52 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.31825418 |
| 53 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.31162383 |
| 54 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.30948981 |
| 55 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.30247869 |
| 56 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.29868319 |
| 57 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.29684962 |
| 58 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.26875290 |
| 59 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.26453927 |
| 60 | CJUN_26792858_Chip-Seq_BT549_Human | 1.26246541 |
| 61 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.26122052 |
| 62 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.24919030 |
| 63 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.24406079 |
| 64 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.24095239 |
| 65 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.22646092 |
| 66 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.22200752 |
| 67 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.22179761 |
| 68 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.20834646 |
| 69 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.20326844 |
| 70 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.19987025 |
| 71 | GATA1_22025678_ChIP-Seq_K562_Human | 1.17682796 |
| 72 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17228498 |
| 73 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.16814586 |
| 74 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.14338540 |
| 75 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.13154478 |
| 76 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12724689 |
| 77 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.12636595 |
| 78 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.11956196 |
| 79 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.11533074 |
| 80 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10523090 |
| 81 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.09399057 |
| 82 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.08882155 |
| 83 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.08507170 |
| 84 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.06176606 |
| 85 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05711510 |
| 86 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05403148 |
| 87 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.05245962 |
| 88 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.04205346 |
| 89 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03199901 |
| 90 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.02735406 |
| 91 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02469908 |
| 92 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.02244141 |
| 93 | ATF3_27146783_Chip-Seq_COLON_Human | 1.00482786 |
| 94 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.99627690 |
| 95 | MAF_26560356_Chip-Seq_TH1_Human | 0.99556956 |
| 96 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.99097584 |
| 97 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.98972669 |
| 98 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.98662689 |
| 99 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.98516162 |
| 100 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.98360448 |
| 101 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.98248517 |
| 102 | * TP53_22127205_ChIP-Seq_IMR90_Human | 0.97745949 |
| 103 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.97437350 |
| 104 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.96318527 |
| 105 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.96318527 |
| 106 | KDM2B_26808549_Chip-Seq_K562_Human | 0.95811574 |
| 107 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.95411441 |
| 108 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.95093864 |
| 109 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94922778 |
| 110 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.94628387 |
| 111 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.94145395 |
| 112 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93391951 |
| 113 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.92709297 |
| 114 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.92648129 |
| 115 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.92366975 |
| 116 | GATA2_19941826_ChIP-Seq_K562_Human | 0.92269278 |
| 117 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.91450118 |
| 118 | SPI1_23127762_ChIP-Seq_K562_Human | 0.91197811 |
| 119 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.90458247 |
| 120 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.89877916 |
| 121 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.89804891 |
| 122 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.88731286 |
| 123 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.88535096 |
| 124 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.87185423 |
| 125 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.85359843 |
| 126 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84934354 |
| 127 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.83567857 |
| 128 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.83429901 |
| 129 | GATA1_19941826_ChIP-Seq_K562_Human | 0.82625799 |
| 130 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.82265850 |
| 131 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.80224254 |
| 132 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.78896467 |
| 133 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.78273562 |
| 134 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77335562 |
| 135 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.77266274 |
| 136 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.77222692 |
| 137 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.76656457 |
| 138 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.75211211 |
| 139 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.74271199 |
| 140 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.73484948 |
| 141 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73468056 |
| 142 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.73170303 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005451_abnormal_body_composition | 3.33846190 |
| 2 | MP0003303_peritoneal_inflammation | 3.18564950 |
| 3 | MP0005360_urolithiasis | 2.95791338 |
| 4 | MP0003436_decreased_susceptibility_to | 2.84899008 |
| 5 | MP0005058_abnormal_lysosome_morphology | 2.82852376 |
| 6 | MP0009840_abnormal_foam_cell | 2.77363243 |
| 7 | MP0002139_abnormal_hepatobiliary_system | 2.49800883 |
| 8 | MP0003195_calcinosis | 2.47314560 |
| 9 | MP0004858_abnormal_nervous_system | 2.40436690 |
| 10 | MP0004510_myositis | 2.27888721 |
| 11 | MP0003172_abnormal_lysosome_physiology | 2.14732645 |
| 12 | MP0000604_amyloidosis | 2.11713444 |
| 13 | MP0008260_abnormal_autophagy | 2.08274968 |
| 14 | MP0006082_CNS_inflammation | 2.06995073 |
| 15 | MP0008438_abnormal_cutaneous_collagen | 1.98746452 |
| 16 | MP0003705_abnormal_hypodermis_morpholog | 1.90858953 |
| 17 | MP0003075_altered_response_to | 1.88526627 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 1.88189793 |
| 19 | MP0003300_gastrointestinal_ulcer | 1.87856421 |
| 20 | MP0001533_abnormal_skeleton_physiology | 1.82709935 |
| 21 | MP0009785_altered_susceptibility_to | 1.80976642 |
| 22 | MP0002735_abnormal_chemical_nociception | 1.79814218 |
| 23 | MP0009764_decreased_sensitivity_to | 1.72898178 |
| 24 | MP0002419_abnormal_innate_immunity | 1.72353606 |
| 25 | MP0003183_abnormal_peptide_metabolism | 1.71239145 |
| 26 | MP0002254_reproductive_system_inflammat | 1.68836118 |
| 27 | MP0000343_altered_response_to | 1.64418552 |
| 28 | MP0004233_abnormal_muscle_weight | 1.63072764 |
| 29 | MP0008875_abnormal_xenobiotic_pharmacok | 1.61636643 |
| 30 | MP0005166_decreased_susceptibility_to | 1.60713943 |
| 31 | MP0010329_abnormal_lipoprotein_level | 1.60279666 |
| 32 | MP0005085_abnormal_gallbladder_physiolo | 1.59518482 |
| 33 | MP0009780_abnormal_chondrocyte_physiolo | 1.57992883 |
| 34 | MP0010352_gastrointestinal_tract_polyps | 1.57183990 |
| 35 | MP0005083_abnormal_biliary_tract | 1.52730594 |
| 36 | MP0003690_abnormal_glial_cell | 1.50793277 |
| 37 | MP0002909_abnormal_adrenal_gland | 1.50392187 |
| 38 | MP0002998_abnormal_bone_remodeling | 1.49805093 |
| 39 | MP0005365_abnormal_bile_salt | 1.49267313 |
| 40 | MP0003950_abnormal_plasma_membrane | 1.47974472 |
| 41 | MP0002877_abnormal_melanocyte_morpholog | 1.43160137 |
| 42 | MP0005076_abnormal_cell_differentiation | 1.42806350 |
| 43 | MP0001835_abnormal_antigen_presentation | 1.40426303 |
| 44 | MP0003656_abnormal_erythrocyte_physiolo | 1.40025151 |
| 45 | MP0003828_pulmonary_edema | 1.39651305 |
| 46 | MP0003566_abnormal_cell_adhesion | 1.39127490 |
| 47 | MP0002148_abnormal_hypersensitivity_rea | 1.37765226 |
| 48 | MP0001849_ear_inflammation | 1.37623660 |
| 49 | MP0001853_heart_inflammation | 1.33901744 |
| 50 | MP0003252_abnormal_bile_duct | 1.33138559 |
| 51 | MP0004947_skin_inflammation | 1.32955457 |
| 52 | MP0003186_abnormal_redox_activity | 1.32713747 |
| 53 | MP0003329_amyloid_beta_deposits | 1.32416845 |
| 54 | MP0004859_abnormal_synaptic_plasticity | 1.32052159 |
| 55 | MP0003091_abnormal_cell_migration | 1.31237538 |
| 56 | MP0005000_abnormal_immune_tolerance | 1.30439232 |
| 57 | MP0002138_abnormal_hepatobiliary_system | 1.26921533 |
| 58 | MP0004270_analgesia | 1.25829860 |
| 59 | MP0005164_abnormal_response_to | 1.24644257 |
| 60 | MP0005464_abnormal_platelet_physiology | 1.24325817 |
| 61 | MP0005257_abnormal_intraocular_pressure | 1.24270216 |
| 62 | MP0003011_delayed_dark_adaptation | 1.20694941 |
| 63 | MP0004185_abnormal_adipocyte_glucose | 1.18385246 |
| 64 | MP0003448_altered_tumor_morphology | 1.17156144 |
| 65 | MP0005167_abnormal_blood-brain_barrier | 1.16064395 |
| 66 | MP0000609_abnormal_liver_physiology | 1.15886979 |
| 67 | MP0001501_abnormal_sleep_pattern | 1.15053826 |
| 68 | MP0008469_abnormal_protein_level | 1.14980398 |
| 69 | MP0005025_abnormal_response_to | 1.14652802 |
| 70 | MP0003453_abnormal_keratinocyte_physiol | 1.12371780 |
| 71 | MP0003045_fibrosis | 1.12138847 |
| 72 | MP0002796_impaired_skin_barrier | 1.11587384 |
| 73 | MP0005319_abnormal_enzyme/_coenzyme | 1.10481947 |
| 74 | MP0003724_increased_susceptibility_to | 1.09704340 |
| 75 | MP0009333_abnormal_splenocyte_physiolog | 1.08127939 |
| 76 | MP0002090_abnormal_vision | 1.07928450 |
| 77 | MP0002060_abnormal_skin_morphology | 1.07839840 |
| 78 | MP0006054_spinal_hemorrhage | 1.07636058 |
| 79 | MP0010386_abnormal_urinary_bladder | 1.07402057 |
| 80 | MP0001216_abnormal_epidermal_layer | 1.07091608 |
| 81 | MP0001968_abnormal_touch/_nociception | 1.06848904 |
| 82 | MP0002118_abnormal_lipid_homeostasis | 1.06615608 |
| 83 | MP0002933_joint_inflammation | 1.06089699 |
| 84 | MP0001845_abnormal_inflammatory_respons | 1.05682782 |
| 85 | MP0005535_abnormal_body_temperature | 1.05463419 |
| 86 | MP0003941_abnormal_skin_development | 1.03906717 |
| 87 | MP0002736_abnormal_nociception_after | 1.01332920 |
| 88 | MP0009046_muscle_twitch | 0.99550212 |
| 89 | MP0004272_abnormal_basement_membrane | 0.98866392 |
| 90 | MP0001666_abnormal_nutrient_absorption | 0.97986297 |
| 91 | MP0004130_abnormal_muscle_cell | 0.97679249 |
| 92 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.97095801 |
| 93 | MP0000685_abnormal_immune_system | 0.96970892 |
| 94 | MP0003879_abnormal_hair_cell | 0.96252291 |
| 95 | MP0002733_abnormal_thermal_nociception | 0.95693202 |
| 96 | MP0005332_abnormal_amino_acid | 0.95278653 |
| 97 | MP0009278_abnormal_bone_marrow | 0.93666614 |
| 98 | MP0004019_abnormal_vitamin_homeostasis | 0.93621642 |
| 99 | MP0004043_abnormal_pH_regulation | 0.93330443 |
| 100 | MP0008004_abnormal_stomach_pH | 0.92736106 |
| 101 | MP0010234_abnormal_vibrissa_follicle | 0.92525494 |
| 102 | MP0001915_intracranial_hemorrhage | 0.91081133 |
| 103 | MP0003806_abnormal_nucleotide_metabolis | 0.89353555 |
| 104 | MP0005448_abnormal_energy_balance | 0.87360573 |
| 105 | MP0002896_abnormal_bone_mineralization | 0.86803416 |
| 106 | MP0008961_abnormal_basal_metabolism | 0.84767382 |
| 107 | MP0001545_abnormal_hematopoietic_system | 0.84227757 |
| 108 | MP0005397_hematopoietic_system_phenotyp | 0.84227757 |
| 109 | MP0003279_aneurysm | 0.83295245 |
| 110 | MP0010155_abnormal_intestine_physiology | 0.83032362 |
| 111 | MP0002405_respiratory_system_inflammati | 0.82717325 |
| 112 | MP0000920_abnormal_myelination | 0.81451432 |
| 113 | MP0002332_abnormal_exercise_endurance | 0.81388679 |
| 114 | MP0002723_abnormal_immune_serum | 0.80653464 |
| 115 | MP0002734_abnormal_mechanical_nocicepti | 0.79958240 |
| 116 | MP0005390_skeleton_phenotype | 0.79177818 |
| 117 | MP0003795_abnormal_bone_structure | 0.79005445 |
| 118 | MP0001440_abnormal_grooming_behavior | 0.78763452 |
| 119 | MP0005621_abnormal_cell_physiology | 0.78370846 |
| 120 | MP0005023_abnormal_wound_healing | 0.77961053 |
| 121 | MP0003221_abnormal_cardiomyocyte_apopto | 0.77955583 |
| 122 | MP0002452_abnormal_antigen_presenting | 0.77252476 |
| 123 | MP0001299_abnormal_eye_distance/ | 0.76960391 |
| 124 | MP0009643_abnormal_urine_homeostasis | 0.76774692 |
| 125 | MP0008873_increased_physiological_sensi | 0.75984212 |
| 126 | MP0005165_increased_susceptibility_to | 0.75364166 |
| 127 | MP0004883_abnormal_blood_vessel | 0.75274147 |
| 128 | MP0010307_abnormal_tumor_latency | 0.74930026 |
| 129 | MP0005501_abnormal_skin_physiology | 0.74900971 |
| 130 | MP0004808_abnormal_hematopoietic_stem | 0.74847206 |
| 131 | MP0000747_muscle_weakness | 0.74325733 |
| 132 | MP0000858_altered_metastatic_potential | 0.74149976 |
| 133 | MP0001881_abnormal_mammary_gland | 0.74074359 |
| 134 | MP0009763_increased_sensitivity_to | 0.73895453 |
| 135 | MP0005310_abnormal_salivary_gland | 0.73327895 |
| 136 | MP0009053_abnormal_anal_canal | 0.73092214 |
| 137 | MP0000371_diluted_coat_color | 0.72937951 |
| 138 | MP0001790_abnormal_immune_system | 0.72136644 |
| 139 | MP0005387_immune_system_phenotype | 0.72136644 |
| 140 | MP0000750_abnormal_muscle_regeneration | 0.71012409 |
| 141 | MP0005409_darkened_coat_color | 0.70533295 |
| 142 | MP0001243_abnormal_dermal_layer | 0.70398692 |
| 143 | MP0001851_eye_inflammation | 0.70199501 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.44223041 |
| 2 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.24360540 |
| 3 | Increased cerebral lipofuscin (HP:0011813) | 4.01821734 |
| 4 | Tetraparesis (HP:0002273) | 3.87399742 |
| 5 | Hydroxyprolinuria (HP:0003080) | 3.69968041 |
| 6 | Abnormality of proline metabolism (HP:0010907) | 3.69968041 |
| 7 | Axonal loss (HP:0003447) | 3.64272104 |
| 8 | Epiphyseal dysplasia (HP:0002656) | 3.56563575 |
| 9 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.48420985 |
| 10 | Cupped ribs (HP:0000887) | 3.41573175 |
| 11 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.40371247 |
| 12 | Neurofibrillary tangles (HP:0002185) | 3.30687448 |
| 13 | Abnormal gallbladder physiology (HP:0012438) | 3.26317836 |
| 14 | Cholecystitis (HP:0001082) | 3.26317836 |
| 15 | Cerebral inclusion bodies (HP:0100314) | 3.04887493 |
| 16 | Nuclear cataract (HP:0100018) | 2.98340445 |
| 17 | Flat acetabular roof (HP:0003180) | 2.89419004 |
| 18 | Abnormality of macrophages (HP:0004311) | 2.87974627 |
| 19 | Premature rupture of membranes (HP:0001788) | 2.86493511 |
| 20 | Xanthomatosis (HP:0000991) | 2.82763930 |
| 21 | Recurrent abscess formation (HP:0002722) | 2.78687952 |
| 22 | Myocardial infarction (HP:0001658) | 2.76694508 |
| 23 | Vacuolated lymphocytes (HP:0001922) | 2.73132480 |
| 24 | Abnormality of the Achilles tendon (HP:0005109) | 2.67846307 |
| 25 | Achilles tendon contracture (HP:0001771) | 2.67211994 |
| 26 | Recurrent bacterial skin infections (HP:0005406) | 2.66602478 |
| 27 | Protuberant abdomen (HP:0001538) | 2.65968565 |
| 28 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.65221405 |
| 29 | Vertebral compression fractures (HP:0002953) | 2.65014546 |
| 30 | Dysostosis multiplex (HP:0000943) | 2.60139561 |
| 31 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.59741932 |
| 32 | Mucopolysacchariduria (HP:0008155) | 2.59741932 |
| 33 | Vitreoretinal degeneration (HP:0000655) | 2.58394747 |
| 34 | Abnormal tarsal ossification (HP:0008369) | 2.54889214 |
| 35 | Interstitial pulmonary disease (HP:0006530) | 2.48732262 |
| 36 | Osteolytic defects of the hand bones (HP:0009699) | 2.47522713 |
| 37 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.47522713 |
| 38 | Short nail (HP:0001799) | 2.41404368 |
| 39 | Gingivitis (HP:0000230) | 2.40127727 |
| 40 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.36615059 |
| 41 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.36615059 |
| 42 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.36615059 |
| 43 | Protrusio acetabuli (HP:0003179) | 2.35959219 |
| 44 | Ovoid vertebral bodies (HP:0003300) | 2.30913006 |
| 45 | Abnormality of the lumbar spine (HP:0100712) | 2.29610740 |
| 46 | Autoimmune thrombocytopenia (HP:0001973) | 2.28518572 |
| 47 | Apathy (HP:0000741) | 2.27699928 |
| 48 | Upper motor neuron abnormality (HP:0002127) | 2.27320853 |
| 49 | Metaphyseal cupping (HP:0003021) | 2.27048685 |
| 50 | Distal lower limb amyotrophy (HP:0008944) | 2.26996419 |
| 51 | Increased serum ferritin (HP:0003281) | 2.26741987 |
| 52 | Distal lower limb muscle weakness (HP:0009053) | 2.26177076 |
| 53 | Sensorimotor neuropathy (HP:0007141) | 2.25939945 |
| 54 | Upper limb amyotrophy (HP:0009129) | 2.25330159 |
| 55 | Distal upper limb amyotrophy (HP:0007149) | 2.25330159 |
| 56 | Thick nail (HP:0001805) | 2.25203696 |
| 57 | Diminished motivation (HP:0000745) | 2.25024001 |
| 58 | Systemic lupus erythematosus (HP:0002725) | 2.22029464 |
| 59 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.19427028 |
| 60 | Abnormality of glycolipid metabolism (HP:0010969) | 2.19427028 |
| 61 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.19427028 |
| 62 | Hypoplastic ischia (HP:0003175) | 2.18404271 |
| 63 | Global brain atrophy (HP:0002283) | 2.15972180 |
| 64 | Irregular epiphyses (HP:0010582) | 2.15399983 |
| 65 | Beaking of vertebral bodies (HP:0004568) | 2.13433913 |
| 66 | Prolonged neonatal jaundice (HP:0006579) | 2.11782080 |
| 67 | Osteoarthritis (HP:0002758) | 2.11495855 |
| 68 | Hand muscle atrophy (HP:0009130) | 2.10504139 |
| 69 | Esophageal varix (HP:0002040) | 2.10123686 |
| 70 | Deep venous thrombosis (HP:0002625) | 2.09049612 |
| 71 | Abnormality of the common coagulation pathway (HP:0010990) | 2.06861646 |
| 72 | Peripheral demyelination (HP:0011096) | 2.04935380 |
| 73 | Cervical subluxation (HP:0003308) | 2.04644476 |
| 74 | Coxa vara (HP:0002812) | 2.03687014 |
| 75 | Increased CSF protein (HP:0002922) | 2.01845401 |
| 76 | Neuronal loss in central nervous system (HP:0002529) | 2.01439704 |
| 77 | Abnormality of the ischium (HP:0003174) | 1.99160631 |
| 78 | Abnormality of the vertebral endplates (HP:0005106) | 1.98467087 |
| 79 | Asymmetric septal hypertrophy (HP:0001670) | 1.97219844 |
| 80 | Supranuclear gaze palsy (HP:0000605) | 1.96002231 |
| 81 | Hyperacusis (HP:0010780) | 1.95966598 |
| 82 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.95539873 |
| 83 | Abnormal gallbladder morphology (HP:0012437) | 1.94982716 |
| 84 | Increased connective tissue (HP:0009025) | 1.94851425 |
| 85 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.94689392 |
| 86 | Thoracolumbar scoliosis (HP:0002944) | 1.94680685 |
| 87 | Skin nodule (HP:0200036) | 1.94586328 |
| 88 | Hypercortisolism (HP:0001578) | 1.91807710 |
| 89 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.91747474 |
| 90 | Stomatitis (HP:0010280) | 1.90915288 |
| 91 | Cholelithiasis (HP:0001081) | 1.89841856 |
| 92 | Intrahepatic cholestasis (HP:0001406) | 1.88295349 |
| 93 | Progressive neurologic deterioration (HP:0002344) | 1.86638009 |
| 94 | Atrophic scars (HP:0001075) | 1.86560189 |
| 95 | Loss of speech (HP:0002371) | 1.86017808 |
| 96 | Hypercholesterolemia (HP:0003124) | 1.85910140 |
| 97 | Thin bony cortex (HP:0002753) | 1.85842831 |
| 98 | Amyloidosis (HP:0011034) | 1.84266154 |
| 99 | Hypobetalipoproteinemia (HP:0003563) | 1.83356124 |
| 100 | Epidermoid cyst (HP:0200040) | 1.83188670 |
| 101 | Mediastinal lymphadenopathy (HP:0100721) | 1.81985880 |
| 102 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.81700844 |
| 103 | Spondylolisthesis (HP:0003302) | 1.80835884 |
| 104 | Pathologic fracture (HP:0002756) | 1.80231365 |
| 105 | Nausea (HP:0002018) | 1.80092221 |
| 106 | Complement deficiency (HP:0004431) | 1.80044255 |
| 107 | Purpura (HP:0000979) | 1.78857945 |
| 108 | Bone pain (HP:0002653) | 1.78523971 |
| 109 | Abdominal distention (HP:0003270) | 1.78380090 |
| 110 | Recurrent skin infections (HP:0001581) | 1.77393256 |
| 111 | Fragile skin (HP:0001030) | 1.77209274 |
| 112 | Mutism (HP:0002300) | 1.77044807 |
| 113 | Flattened epiphyses (HP:0003071) | 1.76742335 |
| 114 | Glomerulonephritis (HP:0000099) | 1.76596329 |
| 115 | Arthropathy (HP:0003040) | 1.76507173 |
| 116 | Cardiomegaly (HP:0001640) | 1.74742591 |
| 117 | Abnormality of complement system (HP:0005339) | 1.74736216 |
| 118 | Hyperparathyroidism (HP:0000843) | 1.74534810 |
| 119 | Hepatosplenomegaly (HP:0001433) | 1.73720682 |
| 120 | Reticulocytosis (HP:0001923) | 1.73398523 |
| 121 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.72692227 |
| 122 | Natal tooth (HP:0000695) | 1.70142787 |
| 123 | Broad face (HP:0000283) | 1.69574125 |
| 124 | Arterial tortuosity (HP:0005116) | 1.69505374 |
| 125 | Hypolipoproteinemia (HP:0010981) | 1.69292360 |
| 126 | Disinhibition (HP:0000734) | 1.69279567 |
| 127 | Joint hemorrhage (HP:0005261) | 1.68081315 |
| 128 | Cerebral aneurysm (HP:0004944) | 1.67528944 |
| 129 | Conjugated hyperbilirubinemia (HP:0002908) | 1.67116764 |
| 130 | Peritonitis (HP:0002586) | 1.66614610 |
| 131 | Fat malabsorption (HP:0002630) | 1.66337110 |
| 132 | Difficulty climbing stairs (HP:0003551) | 1.65871866 |
| 133 | Thoracic kyphosis (HP:0002942) | 1.65643352 |
| 134 | Small epiphyses (HP:0010585) | 1.65550904 |
| 135 | Abnormality of iron homeostasis (HP:0011031) | 1.65519233 |
| 136 | Mitral stenosis (HP:0001718) | 1.65043260 |
| 137 | Orchitis (HP:0100796) | 1.64746885 |
| 138 | Recurrent fungal infections (HP:0002841) | 1.64468901 |
| 139 | Spinal rigidity (HP:0003306) | 1.64252924 |
| 140 | Cardiovascular calcification (HP:0011915) | 1.63534198 |
| 141 | Hypoalphalipoproteinemia (HP:0003233) | 1.63451630 |
| 142 | Vascular calcification (HP:0004934) | 1.63374157 |
| 143 | Vascular tortuosity (HP:0004948) | 1.62527100 |
| 144 | Spastic tetraparesis (HP:0001285) | 1.62511340 |
| 145 | Retinal atrophy (HP:0001105) | 1.62328466 |
| 146 | Malnutrition (HP:0004395) | 1.62069739 |
| 147 | Acanthocytosis (HP:0001927) | 1.62051147 |
| 148 | Turricephaly (HP:0000262) | 1.61469722 |
| 149 | Ankle contracture (HP:0006466) | 1.61393637 |
| 150 | Elevated alkaline phosphatase (HP:0003155) | 1.60929146 |
| 151 | Multiple lipomas (HP:0001012) | 1.60594724 |
| 152 | Subacute progressive viral hepatitis (HP:0006572) | 1.58320707 |
| 153 | Abnormality of the thoracic spine (HP:0100711) | 1.58002752 |
| 154 | Elbow flexion contracture (HP:0002987) | 1.56935972 |
| 155 | Personality changes (HP:0000751) | 1.56403411 |
| 156 | Generalized amyotrophy (HP:0003700) | 1.53145180 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.58716774 |
| 2 | NME2 | 3.42244666 |
| 3 | PBK | 3.40155356 |
| 4 | RIPK4 | 2.83813899 |
| 5 | MST1R | 2.65206599 |
| 6 | TBK1 | 2.59834821 |
| 7 | ERBB4 | 2.57400248 |
| 8 | EPHB1 | 2.56643998 |
| 9 | TAOK2 | 2.50735096 |
| 10 | PRPF4B | 2.48429603 |
| 11 | EPHA3 | 2.34079735 |
| 12 | MAP3K3 | 2.33342401 |
| 13 | KSR2 | 2.30659329 |
| 14 | BMX | 2.13823789 |
| 15 | PAK4 | 2.11948500 |
| 16 | MAP3K9 | 2.06918673 |
| 17 | MAP3K2 | 2.05166522 |
| 18 | IRAK3 | 1.88691646 |
| 19 | MAP3K14 | 1.85956374 |
| 20 | SIK1 | 1.83987126 |
| 21 | ICK | 1.77080701 |
| 22 | ABL2 | 1.67836977 |
| 23 | DDR2 | 1.66628227 |
| 24 | TRIB3 | 1.63097381 |
| 25 | MAP3K1 | 1.58109671 |
| 26 | FGFR4 | 1.54173811 |
| 27 | SMG1 | 1.53507935 |
| 28 | JAK1 | 1.50152144 |
| 29 | NTRK1 | 1.48552024 |
| 30 | RIPK1 | 1.41052559 |
| 31 | TGFBR2 | 1.40384045 |
| 32 | TAOK3 | 1.39118620 |
| 33 | SCYL2 | 1.37523058 |
| 34 | EPHA2 | 1.37002670 |
| 35 | PIM2 | 1.35522372 |
| 36 | NTRK3 | 1.35167069 |
| 37 | MAP3K11 | 1.32136231 |
| 38 | DAPK2 | 1.27097534 |
| 39 | TAOK1 | 1.21907127 |
| 40 | GRK7 | 1.17446966 |
| 41 | RET | 1.15443734 |
| 42 | MET | 1.14652420 |
| 43 | FER | 1.14556186 |
| 44 | MAP2K1 | 1.13585561 |
| 45 | MATK | 1.12870654 |
| 46 | PRKG2 | 1.11002467 |
| 47 | IRAK2 | 1.10905161 |
| 48 | CAMKK1 | 1.07073731 |
| 49 | NEK9 | 1.05027177 |
| 50 | PTK6 | 1.04622421 |
| 51 | SIK3 | 1.03018292 |
| 52 | CDK12 | 1.00732327 |
| 53 | ZAP70 | 1.00664067 |
| 54 | CDC42BPA | 1.00224822 |
| 55 | MAP3K5 | 0.94584732 |
| 56 | TYK2 | 0.94023856 |
| 57 | MAP3K13 | 0.93683217 |
| 58 | MAP3K8 | 0.93572143 |
| 59 | PTK2 | 0.91731022 |
| 60 | JAK2 | 0.90396123 |
| 61 | MAP2K4 | 0.89189236 |
| 62 | MUSK | 0.88236628 |
| 63 | CAMKK2 | 0.87401813 |
| 64 | FGFR3 | 0.87135269 |
| 65 | PAK6 | 0.86968193 |
| 66 | ALK | 0.86414214 |
| 67 | BMPR2 | 0.83935552 |
| 68 | FRK | 0.83768317 |
| 69 | ARAF | 0.83418966 |
| 70 | PRKCH | 0.81593561 |
| 71 | PRKD3 | 0.81182941 |
| 72 | EIF2AK1 | 0.78976564 |
| 73 | FGR | 0.78969038 |
| 74 | IKBKB | 0.76797660 |
| 75 | STK10 | 0.75948684 |
| 76 | MOS | 0.74922869 |
| 77 | MINK1 | 0.74502597 |
| 78 | MST4 | 0.73240564 |
| 79 | TESK2 | 0.72491315 |
| 80 | TESK1 | 0.71922973 |
| 81 | PDPK1 | 0.71663683 |
| 82 | BLK | 0.71018719 |
| 83 | IKBKE | 0.67725429 |
| 84 | MAP3K12 | 0.66534646 |
| 85 | PKN2 | 0.66264670 |
| 86 | EGFR | 0.64781243 |
| 87 | IRAK1 | 0.64043142 |
| 88 | LATS2 | 0.63360663 |
| 89 | CAMK1D | 0.61875916 |
| 90 | PRKD2 | 0.61073429 |
| 91 | DAPK3 | 0.60456123 |
| 92 | GRK5 | 0.60326805 |
| 93 | CDK6 | 0.59449618 |
| 94 | LMTK2 | 0.59327761 |
| 95 | TTN | 0.57400175 |
| 96 | PDGFRA | 0.57084645 |
| 97 | CSK | 0.56861087 |
| 98 | MAP2K3 | 0.56632310 |
| 99 | BRAF | 0.56396646 |
| 100 | GSK3A | 0.53514609 |
| 101 | TRPM7 | 0.52022275 |
| 102 | MTOR | 0.51966409 |
| 103 | MAP2K2 | 0.51410639 |
| 104 | PAK3 | 0.51299438 |
| 105 | PAK2 | 0.50311223 |
| 106 | PRKCD | 0.49389344 |
| 107 | PDK1 | 0.49191672 |
| 108 | EEF2K | 0.48827546 |
| 109 | PLK2 | 0.46779261 |
| 110 | MELK | 0.46280305 |
| 111 | IRAK4 | 0.45045041 |
| 112 | PTK2B | 0.44096726 |
| 113 | ABL1 | 0.41988615 |
| 114 | LIMK1 | 0.41064593 |
| 115 | PRKCE | 0.40751786 |
| 116 | PDK2 | 0.40438800 |
| 117 | CDK5 | 0.40263880 |
| 118 | STK38 | 0.38061059 |
| 119 | KSR1 | 0.37716555 |
| 120 | LRRK2 | 0.36121504 |
| 121 | SGK3 | 0.35388368 |
| 122 | RAF1 | 0.34755455 |
| 123 | HCK | 0.34617203 |
| 124 | CHUK | 0.34161500 |
| 125 | JAK3 | 0.33862651 |
| 126 | CAMK2G | 0.32537657 |
| 127 | INSR | 0.32482488 |
| 128 | PDGFRB | 0.32358245 |
| 129 | PRKACG | 0.32349699 |
| 130 | RPS6KA2 | 0.31969807 |
| 131 | SRC | 0.31538513 |
| 132 | RPS6KC1 | 0.31497370 |
| 133 | RPS6KL1 | 0.31497370 |
| 134 | MAP3K6 | 0.30634805 |
| 135 | STK24 | 0.29433199 |
| 136 | ILK | 0.27855288 |
| 137 | CLK1 | 0.27823306 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.18630200 |
| 2 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.99799520 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.97638360 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.86938869 |
| 5 | Lysosome_Homo sapiens_hsa04142 | 1.81103344 |
| 6 | Phagosome_Homo sapiens_hsa04145 | 1.79252748 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.78002645 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 1.74384393 |
| 9 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.73195810 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.65293276 |
| 11 | Tuberculosis_Homo sapiens_hsa05152 | 1.52329077 |
| 12 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.51252645 |
| 13 | Legionellosis_Homo sapiens_hsa05134 | 1.46798237 |
| 14 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.44079324 |
| 15 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.43626237 |
| 16 | Mineral absorption_Homo sapiens_hsa04978 | 1.39172212 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.38684126 |
| 18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.35484119 |
| 19 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.34717060 |
| 20 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.33625909 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.32777524 |
| 22 | Malaria_Homo sapiens_hsa05144 | 1.29189296 |
| 23 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.28508343 |
| 24 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.26992317 |
| 25 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.26911447 |
| 26 | Salmonella infection_Homo sapiens_hsa05132 | 1.26631970 |
| 27 | Pertussis_Homo sapiens_hsa05133 | 1.26561083 |
| 28 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.20584962 |
| 29 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.16575790 |
| 30 | Bile secretion_Homo sapiens_hsa04976 | 1.14841877 |
| 31 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.13973357 |
| 32 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.12484692 |
| 33 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.11905462 |
| 34 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.11187354 |
| 35 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.08647244 |
| 36 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.08453428 |
| 37 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.07424860 |
| 38 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.07272279 |
| 39 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.05704727 |
| 40 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.04726354 |
| 41 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.01708193 |
| 42 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.00002705 |
| 43 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.98602684 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 0.96198435 |
| 45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.94618237 |
| 46 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.92809747 |
| 47 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.92199341 |
| 48 | Amoebiasis_Homo sapiens_hsa05146 | 0.91248550 |
| 49 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.88394991 |
| 50 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.86708788 |
| 51 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.86353464 |
| 52 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.86328470 |
| 53 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.86226898 |
| 54 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.85155792 |
| 55 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.84953884 |
| 56 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.84034569 |
| 57 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.83172918 |
| 58 | Prion diseases_Homo sapiens_hsa05020 | 0.83161475 |
| 59 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.82898441 |
| 60 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.82312042 |
| 61 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.79877429 |
| 62 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.78290110 |
| 63 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.78080337 |
| 64 | Focal adhesion_Homo sapiens_hsa04510 | 0.78025623 |
| 65 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.77134529 |
| 66 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.75919329 |
| 67 | Thyroid cancer_Homo sapiens_hsa05216 | 0.75479630 |
| 68 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.74902597 |
| 69 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.73785519 |
| 70 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.72997376 |
| 71 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.72038453 |
| 72 | Measles_Homo sapiens_hsa05162 | 0.70823034 |
| 73 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.69285685 |
| 74 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.67646751 |
| 75 | Apoptosis_Homo sapiens_hsa04210 | 0.64708017 |
| 76 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.63825622 |
| 77 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.63812950 |
| 78 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.62946745 |
| 79 | Shigellosis_Homo sapiens_hsa05131 | 0.62110747 |
| 80 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.61225534 |
| 81 | Asthma_Homo sapiens_hsa05310 | 0.60232497 |
| 82 | Adherens junction_Homo sapiens_hsa04520 | 0.59460144 |
| 83 | Insulin resistance_Homo sapiens_hsa04931 | 0.58196702 |
| 84 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58019271 |
| 85 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.56678574 |
| 86 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.56420750 |
| 87 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.55802035 |
| 88 | Hepatitis C_Homo sapiens_hsa05160 | 0.55080947 |
| 89 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.54986706 |
| 90 | Endometrial cancer_Homo sapiens_hsa05213 | 0.54897951 |
| 91 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.53107436 |
| 92 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.52448183 |
| 93 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.52289482 |
| 94 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.52012503 |
| 95 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.51755375 |
| 96 | Bladder cancer_Homo sapiens_hsa05219 | 0.51720762 |
| 97 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.51684450 |
| 98 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.51294820 |
| 99 | Allograft rejection_Homo sapiens_hsa05330 | 0.50661839 |
| 100 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.50531958 |
| 101 | Prostate cancer_Homo sapiens_hsa05215 | 0.50165869 |
| 102 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.49766895 |
| 103 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.49457720 |
| 104 | Histidine metabolism_Homo sapiens_hsa00340 | 0.49425759 |
| 105 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.49336336 |
| 106 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.49124815 |
| 107 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.48635477 |
| 108 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.48160400 |
| 109 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.47357658 |
| 110 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.46922956 |
| 111 | Other glycan degradation_Homo sapiens_hsa00511 | 0.46512699 |
| 112 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.46450643 |
| 113 | Galactose metabolism_Homo sapiens_hsa00052 | 0.45815861 |
| 114 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.45053292 |
| 115 | Influenza A_Homo sapiens_hsa05164 | 0.44625867 |
| 116 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.44078924 |
| 117 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.44035818 |
| 118 | Glioma_Homo sapiens_hsa05214 | 0.43365391 |
| 119 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.43281888 |
| 120 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.42715453 |
| 121 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.41713133 |
| 122 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.41628964 |
| 123 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.41432354 |
| 124 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.41126658 |
| 125 | Endocytosis_Homo sapiens_hsa04144 | 0.38626773 |
| 126 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.38417903 |
| 127 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38407188 |
| 128 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37879439 |
| 129 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.37804781 |
| 130 | GABAergic synapse_Homo sapiens_hsa04727 | 0.35535346 |
| 131 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.35274882 |
| 132 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.33701486 |
| 133 | Carbon metabolism_Homo sapiens_hsa01200 | 0.33574927 |
| 134 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.33456233 |
| 135 | Insulin secretion_Homo sapiens_hsa04911 | 0.33413507 |

